Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trial

Hospitalized patients with cancer are at an increased risk of developing venous thromboembolism (VTE). The recommendation for routine pharmacologic thromboprophylaxis in hospitalized patients with cancer to prevent VTE is based on extrapolation of results from noncancer cohorts. There are limited da...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood advances 2020-05, Vol.4 (10), p.2254-2260
Hauptverfasser:	Zwicker, Jeffrey I., Roopkumar, Joanna, Puligandla, Maneka, Schlechter, Benjamin L., Sharda, Anish V., Peereboom, David, Joyce, Robin, Bockorny, Bruno, Neuberg, Donna, Bauer, Kenneth A., Khorana, Alok A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticoagulants - adverse effects Clinical Trials and Observations Enoxaparin - adverse effects Heparin, Low-Molecular-Weight - adverse effects Humans Neoplasms - complications Neoplasms - drug therapy Venous Thromboembolism - drug therapy Venous Thromboembolism - etiology Venous Thromboembolism - prevention & control
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!